This exclusion was written into the Medicare Part D prescription drug program when it was created, reflecting the political reality that weight loss medications were viewed as lifestyle drugs rather than treatments for serious medical conditions
These medications work by mimicking naturally occurring hormones that regulate appetite and blood sugar
Overpriced GLP-1 drugs are a great place to start
Start your intake Clinical Trial Data: Context and Individual Variation Tirzepatide's dual GLP-1 and GIP receptor agonism produced mean weight loss of 22.5% over 68 weeks in SURMOUNT-1 trials, compared to semaglutide's approximately 14-15% at comparable follow-up
Studies have shown that it can counteract the deleterious effects of excess NO in chronic inflammation models
Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, et al